NASDAQ:MAZE | Free Cash Flow | Maze Therapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2024-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$39.11M$93,000.00-$39.21M
2025-12-31-$27.73M$34,000.00-$27.76M
2025-03-31-$29.52M$299,000.00-$29.82M
2024-12-31-$22.45M$605,000.00-$23.06M
2024-03-31-$23.44M$279,000.00-$23.72M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$111.94M$794,000.00-$112.73M
2024-12-31$75.95M$1.15M$74.81M143.22%